Tagged Articles

AbbVie 91 articles

Man blames testosterone product for disabling stroke

Brian DeMatteo was the kind of guy who was always out playing tennis or surfing. But the 64-yer-old Boston businessman says it’s impossible to live that life after he suffered a spinal stroke in 2012 that left him in a wheelchair with chronic pain. He blames his injury on the testosterone replacement therapy AndroGel, and says its maker, AbbVie, is to blame for aggressively marketing the drug to men as a fountain of youth. DeMatteo is one of about 4,200 men who have filed lawsuits against AndroGel and other manufacturers of testosterone treatments for off-label marketing of the medication for ... Read More

Man blames heart attack on Low T treatment

AbbVie Inc.’s commercials promoting its AndroGel testosterone replacement therapy for so-called Low T piqued Jeffrey Konrad’s interest. The commercials claimed that low levels of the male hormone could hamper libido, cause weight gain, and reduce muscle mass. Men who suffered from these and other symptoms of Low T were encouraged to ask their doctors if they were candidates for testosterone therapy. Konrad, of Tennessee, was intrigued enough to talk to his doctor and, in 2010, obtained his own prescription for AndroGel. Sixty-five days later, he suffered a heart attack. That’s when Jeffrey learned that testosterone treatments were intended for men ... Read More

Testosterone trial to begin June 6

Both parties in the first bellwether trial in a multidistrict litigation (MDL) of about 7,000 cases alleging cardiovascular risk with testosterone replacement therapy agree that the trial should not be split into a liability phase and a separate damages phase, according to Law360. The MDL targets several different manufacturers of testosterone replacement therapies, but the first six bellwether trials name AbbVie Laboratories, maker of the top selling AndroGel. Those suing the drug companies claim that they were pushed into asking their doctors for the hormone treatment by manufacturers’ aggressive marketing campaigns that promised to boost libido, help with weight loss and ... Read More

First Low T side effects trial to begin June 5

The first trial among more than 2,000 in a class-action lawsuit accusing several manufacturers of testosterone treatments of not adequately warning users of the potential for cardiovascular side effects with use of the hormone therapy, is scheduled to begin June 5, according to the Cook County Record. The class action lawsuits date back to 2014 and name drug companies such as AbbVie, Besins, Eli Lily and GlaxoSmithKline. The lawsuits were consolidated in the U.S. District Court for Northern Illinois in Chicago. Plaintiffs allege the testosterone replacement therapies were promoted for off-label uses, including diabetes, AIDS, cancer, depression and anxiety. Specifically, ... Read More

Man says testosterone gel harmed his wife, kids

Andrew Simpson and his wife Tiziana are suing a West Hollywood pharmacy, a Santa Monica integrative medicine center, two doctors and a pharmacist alleging the topical testosterone replacement therapy he was prescribed caused unexpected side effects in his wife and children after coming in contact with him. The Simpsons lawsuit was filed in Los Angeles Superior Court against Green Earth Compounding Pharmacy, the Akasha Center for Integrative Medicine, and the doctors at the clinic who allegedly prescribed the hormone treatment to Andrew Simpson. The lawsuit claims the doctors did not warn him that accidental exposure to the testosterone gel could ... Read More

Testosterone Replacement Therapy trial requires Doc to reveal payments

A Boston-area doctor notorious for pushing testosterone replacement therapy to his patients for the past three decades was ordered to turn over his tax records indicating how much money he was paid by manufacturers of testosterone drugs. The order was made by U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois regarding a multidistrict litigation (MDL) accusing testosterone replacement therapy manufacturers of promoting testosterone treatment for so-called Low T without revealing that use of the hormone can cause serious medical problems, including life threatening heart attacks, strokes and blood clots. AbbVie is in the hot seat for ... Read More

Testosterone replacement therapy makers can’t dodge trials

U.S. District Judge Matthew Kennelly dissed almost all the arguments AbbVie and Abbott Laboratories made for a summary judgment before the first of seven bellwether trials involving cardiovascular risks with the testosterone replacement treatment AndroGel begins, Law360 reported. The drug companies face more than 7,000 lawsuits in a sprawling multidistrict litigation (MDL) involving several different manufacturers of testosterone replacement therapies. As the maker of the top selling AndroGel, AbbVie will sit in the hot seat for all seven of the selected bellwethers. The first trial is set to begin in June. Plaintiffs suing AbbVie and other testosterone treatment manufacturers allege ... Read More

Testosterone replacement therapy data raises concerns

As AbbVie gears up to face the first trial later this year in a class action lawsuit alleging cardiovascular risks with its one-time blockbuster testosterone replacement therapy AndroGel, the company is facing a wave of research that raises questions about whether the benefits of the hormone treatment actually outweigh the risks. The first is the ongoing T Trials, conducted at a dozen sites across the country involving 790 men age 65 or older. The clinical trial is supported by the National Institutes of Health and is designed to investigate whether AndroGel can improve anemia, improve bone strength, and help cognition. ... Read More

Georgia man sues testosterone treatment makers alleging serious injuries

A Georgia man has joined a lawsuit against several manufacturers of testosterone replacement therapies alleging the hormone treatment caused him to suffer numerous injuries including deep vein thrombosis. He claims the drug companies aggressively marketed the drugs to consumers but failed to warn of dangerous testosterone side effects. Johnny Hall’s lawsuit names Endo Pharmaceuticals Inc., Auxillium Pharmaceuticals Inc, GlaxoSmithKline LLC, Eli Lily and Company, Lilly USA LLC, Acrux Commerical Pty Ltd., and Acrux DDS Pty Ltd. He filed the suit in the U.S. District Court for the Northern District of Illinois. According to his complaint, Hall developed deep vein thrombosis ... Read More

direct-to-consumer advertising likely increases testosterone treatment sales

The U.S. and New Zealand are the only countries in the world that allow drug companies to advertise directly to consumers. A new study published in the Journal of the American Medical Association (JAMA) shows just how powerful that opportunity is for Big Pharma. Direct-to-consumer advertising in the U.S. increased substantially from 2009 to 2013. The study focused on the marketing of testosterone replacement therapies, the biggest selling product being AndroGel manufactured by AbbVie. Testosterone therapy is intended for men with hypogonadism, a condition in which the body does not produce enough of the male hormone due to defect or ... Read More